Attenuated hypothalamo-pituitary-adrenal axis responses to immune challenge during pregnancy: The neurosteroid-opioid connection

Journal of Physiology

Volumn 586, Issue 2, 2008, Pages 369-375

  Brunton, Paula J ^a   Russell, John A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; ENKEPHALIN; GLUCOCORTICOID; INTERLEUKIN 1BETA; MU OPIATE RECEPTOR; NEUROSTEROID; NORADRENALIN; OPIATE; PROGESTERONE; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE;

BRAIN STEM RESPONSE; CELL ACTIVATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; EMOTIONAL STRESS; EVOKED RESPONSE; HORMONE ACTION; HORMONE DETERMINATION; HORMONE RELEASE; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; MATERNAL STRESS; NERVE CELL; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; PHYSICAL STRESS; POSTSYNAPTIC POTENTIAL; PREGNANCY; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; THALAMUS MIDLINE NUCLEUS; THIRD TRIMESTER PREGNANCY; UPREGULATION; ARTICLE; BIOSYNTHESIS; BRAIN FUNCTION; BRAIN STEM; CORTICOSTERONE RELEASE; HORMONE RESPONSE; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MORPHOLOGICAL ADAPTATION; NERVE CELL STIMULATION; NEUROPHYSIOLOGY; NORADRENERGIC NERVE CELL; SOLITARY TRACT NUCLEUS;

ADAPTATION, BIOLOGICAL; ANALGESICS, OPIOID; ANIMALS; FEMALE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-1BETA; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PREGNANCY, ANIMAL; RATS; STRESS;

EID: 38149064531     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.146233     Document Type: Conference Paper

References (47)

1. Barker DJ (2002). Fetal programming of coronary heart disease. Trends Endocrinol Metab 13, 364-368.
2. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K & Clark PM (1993). Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth. Diabetologia 36, 62-67.
3. Benediktsson R, Calder AA, Edwards CRW & Seckl JR (1997). Placental 11β-hydroxysteroid dehydrogenase: A key regulator of fetal glucocorticoid exposure. Clin Endocrinol 46, 161-166.
4. Besedovsky HO, Del Rey A, Klusman I, Furukawa H, Monge Arditi G & Kabiersch A (1991). Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem Mol Biol 40, 613-618.
5. Brunton PJ, Bales J & Russell JA (2006). Neuroendocrine stress but not feeding responses to centrally administered neuropeptide Y are suppressed in pregnant rats. Endocrinology 147, 3737-3745.
6. Brunton PJ, Meddle SL, Ma S, Ochedalski T, Douglas AJ & Russell JA (2005). Endogenous opioids and attenuated hypothalamic-pituitary-adrenal axis responses to immune challenge in pregnant rats. J Neurosci 25, 5117-5126.
7. Brunton PJ & Russell JA (2003). Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats. J Neuroendocrinol 15, 633-637.
8. Brussaard AB, Devay P, Leyting-Vermeulen JL & Kits KS (1999). Changes in properties and neurosteroid regulation of GABAergic synapses in the supraoptic nucleus during the mammalian female reproductive cycle. J Physiol 516, 513-524.
9. Buckingham JC & Cooper TA (1986). Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat. Neuroendocrinology 42, 421-426.
10. Buller KM, Allen T, Wilson LD, Munro F & Day TA (2004). A critical role for the parabrachial nucleus in generating central nervous system responses elicited by a systemic immune challenge. J Neuroimmunol 152, 20-32.
11. Buller KM, Hamlin AS & Osborne PB (2005). Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1β responses using c-fos expression in the rat brain. Neuropharmacology 49, 230-242.
12. Buller KM, Xu Y & Day TA (1998). Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β. J Neuroendocrinol 10, 519-528.
13. Buller KM, Xu Y, Dayas CV & Day TA (2001). Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1β-induced HPA axis responses. Neuroendocrinology 73, 129-138.
14. Cao C, Matsumura K, Yamagata K & Watanabe Y (1996). Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: A possible site of prostaglandin synthesis responsible for fever. Brain Res 733, 263-272.
15. Concas A, Mostallino MC, Porcu P, Follesa P, Barbaccia ML, Trabucchi M, Purdy RH, Grisenti P & Biggio G (1998). Role of brain allopregnanolone in the plasticity of γ-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A 95, 13284-13289.
16. Crane JW, Buller KM & Day TA (2003). Evidence that the bed nucleus of the stria terminalis contributes to the modulation of hypophysiotropic corticotropin-releasing factor cell responses to systemic interleukin-1β. J Comp Neurol 467, 232-242.
17. da Costa APC, Wood S, Ingram CD & Lightman SL (1996). Region-specific reduction in stress-induced c-fos mRNA expression during pregnancy and lactation. Brain Res 742, 177-184.
18. Douglas AJ, Johnstone H, Brunton P & Russell JA (2000). Sex-steroid induction of endogenous opioid inhibition on oxytocin secretory responses to stress. J Neuroendocrinol 12, 343-350.
19. Ericsson A, Arias C & Sawchenko PE (1997). Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci 17, 7166-7179.
20. Ericsson A, Kovacs KJ & Sawchenko PE (1994). A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14, 897-913.
21. Ericsson A, Liu C, Hart RP & Sawchenko PE (1995). Type 1 interleukin-1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361, 681-698.
22. Fride E & Weinstock M (1988). Prenatal stress increases anxiety related behavior and alters cerebral lateralization of dopamine activity. Life Sci 42, 1059-1065.
23. Habib KE, Gold PW & Chrousos GP (2001). Neuroendocrinology of stress. Endocrinol Metab Clin North Am 30, 695-728.
24. Harbuz MS, Stephanou A, Sarlis N & Lightman SL (1992). The effects of recombinant human interleukin (IL)-1α, IL-1β or IL-6 on hypothalamo-pituitary-adrenal axis activation. J Endocrinol 133, 349-355.
25. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC & Cullinan WE (2003). Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24, 151-180.
26. Johnstone HA, Wigger A, Douglas AJ, Neumann ID, Landgraf R, Seckl JR & Russell JA (2000). Attenuation of hypothalamic-pituitary-adrenal axis stress responses in late pregnancy: Changes in feedforward and feedback mechanisms. J Neuroendocrinol 12, 811-822.
27. Komaki G, Arimura A & Koves K (1992). Effect of intravenous injection of IL-1beta on PGE2 levels in several brain areas as determined by microdialysis. Am J Physiol Endocrinol Metabol 262, E246-E251.
28. Lacroix S & Rivest S (1998). Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem 70, 452-466.
29. Levitt NS, Lambert EV, Woods D, Hales CN, Andrew R & Seckl JR (2000). Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young south african adults: Early programming of cortisol axis. J Clin Endocrinol Metab 85, 4611-4618.
30. Levitt NS, Lindsay RS, Holmes MC & Seckl JR (1996). Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64, 412-418.
31. Li HY, Ericsson A & Sawchenko PE (1996). Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci U S A 93, 2359-2364.
32. Lindsay RS, Lindsay RM, Waddell BJ & Seckl JR (1996). Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: Studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia 39, 1299-1305.
33. Mouihate A, Clerget-Froidevaux MS, Nakamura K, Negishi M, Wallace JL & Pittman QJ (2002). Suppression of fever at near term is associated with reduced COX-2 protein expression in rat hypothalamus. Am J Physiol Regul Integr Comp Physiol 283, R800-R805.
34. Nakamura H, Seto T, Hatta K, Matsuzaki I, Nagase H, Yoshida M & Ogino K (1998). Central administration of interleukin-1β reduces natural killer cell activity in non-pregnant rats, but not in pregnant rats. Psychoneuroendocrinology 23, 651-659.
35. Neumann ID, Johnstone HA, Hatzinger M, Liebsch G, Shipston M, Russell JA, Landgraf R & Douglas AJ (1998). Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes. J Physiol 508, 289-300.
36. Niimi M, Sato M, Wada Y, Takahara J & Kawanishi K (1996). Effect of central and continuous intravenous injection of interleukin-1beta on brain c-fos expression in the rat: Involvement of prostaglandins. Neuroimmunomodulation 3, 87-92.
37. Parsadaniantz SM, Gaillet S, Malaval F, Lenoir V, Batsche E, Barbanel G, Gardier A, Terlain B, Jacquot C, Szafarczyk A, Assenmacher I & Kerdelhue B (1995). Lesions of the afferent catecholaminergic pathways inhibit the temporal activation of the CRH and POMC gene expression and ACTH release induced by human interleukin-1beta in the male rat. Neuroendocrinology 62, 586-595.
38. Patchev VK, Hassan AHS, Holsboer F & Almeida OFX (1996). The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15, 533-540.
39. Rivest S, Lacroix S, Vallieres L, Nadeau S, Zhang J & Laflamme N (2000). How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Exp Biol Med 223, 22-38.
40. Rivier C (1993). Neuroendocrine effects of cytokines in the rat. Rev Neurosci 4, 223-237.
41. Sawchenko PE & Swanson LW (1981). Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science 214, 685-687.
42. 2α in the brain in interleukin 1β-induced adrenocorticotropin secretion in the rat. Cytokine 7, 710-712.
43. Weidenfeld J, Abramsky O & Avadia H (1989). Evidence for the involvement of the central adrenergic system in interleukin 1-induced adrenocortical response. Neuropharmacology 28, 1411-1414.
44. Welberg LAM, Seckl JR & Holmes MC (2000). Inhibition of 11β-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring. Eur J Neurosci 12, 1047-1054.
45. Welberg LAM, Thrivikraman KV & Plotsky PM (2005). Chronic maternal stress inhibits the capacity to up-regulate placental 11β-hydroxysteroid dehydrogenase type 2 activity. J Endocrinol 186, R7-R12.
46. Xu Y, Day TA & Buller KM (1999). The central amygdala modulates hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β administration. Neuroscience 94, 175-183.
47. 2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur J Neurosci 11, 2651-2668.